Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MDCO

Medicines (MDCO) Stock Price, News & Analysis

Medicines logo

About Medicines Stock (NASDAQ:MDCO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$84.90
$84.90
50-Day Range
$84.90
$84.90
52-Week Range
$17.81
$84.98
Volume
N/A
Average Volume
9.55 million shs
Market Capitalization
$6.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

The Medicines Company, a biopharmaceutical company, focuses on developing therapeutics for the treatment of therosclerotic cardiovascular disease. The company is developing Inclisiran, an investigational RNA interference therapeutic that inhibits production of proprotein convertase subtilisin/kexin type 9, which controls LDL-cholesterol levels. It has collaboration agreement with Alnylam Pharmaceuticals, Inc. The Medicines Company was founded in 1996 and is headquartered in Parsippany, New Jersey.

Remove Ads
Receive MDCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicines and its competitors with MarketBeat's FREE daily newsletter.

MDCO Stock News Headlines

Gilead Sciences - Leader In HIV Medicines
Quitter’s Day is here—don’t let your financial goals slip away
Maybe you’ve heard of Quitter’s Day… It’s the second Friday in January… And it’s the day that most people throw in the towel on their New Year’s resolution. And look, I’m not judging if you’ve already given up on yours… Most people make one critical mistake when setting their resolution: They try to take on too much at once. Whether it's hitting the gym or cleaning up your personal finances… Getting the results you want takes time - and patience. That’s why I’ve developed my 2025 Income Gameplan.
See More Headlines

MDCO Stock Analysis - Frequently Asked Questions

The Medicines Company (NASDAQ:MDCO) issued its quarterly earnings results on Wednesday, October, 30th. The company reported ($0.92) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.80) by $0.12.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicines investors own include Bristol-Myers Squibb (BMY), NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA) and Salesforce (CRM).

Company Calendar

Last Earnings
10/30/2019
Today
3/19/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MDCO
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-123,160,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.14 million
Price / Cash Flow
N/A
Book Value
($0.30) per share
Price / Book
-283.00

Miscellaneous

Free Float
N/A
Market Cap
$6.77 billion
Optionable
Optionable
Beta
1.10
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:MDCO) was last updated on 3/19/2025 by MarketBeat.com Staff
From Our Partners